Clinical Publications

Insights from
your peers

NovoSorb® BTM is cleared for a variety of challenging indications. Surgeons from multiple specialties have conducted research on BTM to evaluate efficacy and outcomes.


Complex Wounds

  • 2019 Damkat-Thomas L, Greenwood JE & Wagstaff MJD ‘A synthetic Biodegradable Temporising Matrix in degloving lower extremity trauma reconstruction: A case report.’ PRS – Global Open;02; 1-4

  • 2015b Wagstaff MJD, Schmitt B, Caplash Y & Greenwood JE ‘Free flap donor site reconstruction: A prospective case series using an optimized polyurethane temporizing matrix.’ Eplasty; 15: 231-48


Necrotising fasciitis

  • 2019 Sreedharan S, Morrison E, Cleland H, Ricketts S & Bruscino-Raiola F ‘Biodegradable temporising matrix for necrotising soft tissue infections: a case report.’ Australian Journal of Plastic Surgery; 2(1): 106-109

  • 2019 Wagstaff MJD, Salna IM, Caplash Y & Greenwood JE ‘Biodegradable Temporising Matrix (BTM) for the reconstruction of defects following serial debridement for necrotising fasciitis: A case series.’ Burns Open; 3:12-30



  • 2020 Partain KP, Noffsinger D, Thakker RK, Fabia R ‘Pediatric limb salvage after severe thermal injury’ Burns Open Feb 2020

  • Treatment of a Full-Thickness Burn Injury With NovoSorb Biodegradable Temporizing Matric and RECELL Autologous Skin Cell Suspension: A Case Series – 25th November 2019



  • 2015a Wagstaff MJD, Schmitt B, Coghlan P, Finkemeyer JP, Caplash Y & Greenwood JE ‘A biodegradable polyurethane dermal matrix in reconstruction of free flap donor site: A pilot study.’ Eplasty; 15: 102-18

  • 2014 Dearman BL, Li A & Greenwood JE ‘Optimization of a polyurethane dermal matrix and experience with a polymer-based cultured composite skin.’ Journal of Burn Care & Research; 35(5):437-48